New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like For infants born extremely preterm, redirection of care discussions occurred less often for Black and Hispanic infants March 12, 2024 Study reveals gaps in gestational diabetes diagnosis in pregnant women December 17, 2024 CKM syndrome leads to elevated cardiovascular disease risk earlier in life November 11, 2024
For infants born extremely preterm, redirection of care discussions occurred less often for Black and Hispanic infants March 12, 2024